CNS Pharmaceuticals, Inc.

NASDAQ:CNSP

0.1131 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Assets:
Current Assets:
Cash & Cash Equivalents 0.54910.0555.00514.0397.2410.2830.111
Short Term Investments 0000000
Cash and Short Term Investments 0.54910.0555.00514.0397.2410.2830.111
Net Receivables 0000000
Inventory 0000000
Other Current Assets 0.842.5092.4731.4560.6530.0330.052
Total Current Assets 1.38812.5657.47715.4967.8940.5880.162
Non-Current Assets:
Property, Plant & Equipment, Net 0.0050.0060.0160.0230.01800
Goodwill 0000000
Intangible Assets 0000000
Goodwill and Intangible Assets 0000000
Long Term Investments 0000000
Tax Assets 0000000
Other Non-Current Assets 0.3080.4831.2640.334-00.0950
Total Non-Current Assets 0.3130.4881.280.3580.0180.0950
Total Assets 1.70113.0538.75715.8537.9120.6830.162
Liabilities & Equity:
Current Liabilities:
Account Payables 5.8323.6821.5230.9460.2890.1290.057
Short Term Debt 0.3010.410.3880.43900.3170.122
Tax Payables 0000000
Deferred Revenue -5.83200000.0240
Other Current Liabilities 5.8320.8280.2250.520.0220.7630.041
Total Current Liabilities 6.1334.922.1361.9050.3111.2330.221
Non-Current Liabilities:
Long Term Debt 0000000
Deferred Revenue Non-Current 0000000
Deferred Tax Liabilities Non-Current 0000000
Other Non-Current Liabilities 04.09200000
Total Non-Current Liabilities 04.0920000.4460.179
Total Liabilities 6.1334.922.1361.9050.3111.2330.221
Equity:
Preferred Stock 0000000
Common Stock 0.0060.0020.0280.0240.0160.0130.01
Retained Earnings -69.567-50.716-34.983-20.946-11.488-7.611-0.219
Accumulated Other Comprehensive Income/Loss 000-0-000
Other Total Stockholders Equity 65.12958.84741.57734.8719.0737.0490.151
Total Shareholders Equity -4.4328.1336.62213.9487.601-0.549-0.059
Total Equity -4.4328.1336.62213.9487.601-0.549-0.059
Total Liabilities & Shareholders Equity 1.70113.0538.75715.8537.9120.6830.162